Introduction of SARS in France, March–April, 2003
Open accessThe DOI matches its Crossref record.
Abstract
We describe severe acute respiratory syndrome (SARS) in France.Patients meeting the World Health Organization definition of a suspected case underwent a clinical, radiologic, and biologic assessment at the closest university-affiliated infectious disease ward.Suspected cases were immediately reported to the Institut de Veille Sanitaire.Probable case-patients were isolated, their contacts quarantined at home, and were followed for 10 days after exposure.Five probable cases occurred from March through April 2003; four were confirmed as SARS coronavirus by reverse transcription-polymerase chain reaction, serologic testing, or both.The index case-patient (patient A), who had worked in the French hospital of Hanoi, Vietnam, was the most probable source of transmission for the three other confirmed cases; two had been exposed to patient A while on the Hanoi-Paris flight of March 22-23.Timely detection, isolation of probable case-patients, and quarantine of their contacts appear to have been effective in preventing the secondary spread of SARS in France.S evere acute respiratory syndrome (SARS) was recent- ly identified as a new clinical entity (1).SARS likely originated in the Guangdong Province of People's Republic of China (2) and subsequently spread worldwide as infected persons traveled.During the 2003 outbreak, SARS was primarily transmitted by person-to-person contact between healthcare workers or household members and ill patients (2).Community transmission also occurred in several of the most affected areas, and an explosive outbreak from a common source occurred in Amoy Garden in Hong-Kong (3).As of June 2003, a total of 8,477 probable cases and 811 deaths had been reported from 32 countries (4).A novel coronavirus has been identified as the cause of SARS (5-7).Based on current knowledge, SARS is transmitted from symptomatic patients by close direct or indirect contacts through respiratory droplet secretions (2).In specific situations, other modes of transmission, such as airborne spread, may be possible (8).The incubation period ranges from 2 to 10 days, allowing SARS to spread over long distances by infected persons who travel (8,9).We describe how SARS was introduced in France through a single patient who returned from Vietnam on March 23 and present data that suggest transmission from this patient to other passengers may have occurred during his flight back from Hanoi to Paris. Materials and MethodsAfter the World Health Organization (WHO) alert on March 12, 2003, a centralized surveillance system was set up for SARS in France (10).All persons who returned from an area affected by recent transmission, had been in contact with a probable case during the previous 10 days, and in whom fever was >38°C, with cough or difficult breathing, were advised to call the emergency service.These persons were transported to the closest universityaffiliated infectious disease ward or one of the nine infectious disease wards designated as a regional reference center in the French plan of action against bioterrorism, using masks for droplet protection.After performing clinical and Introduction of SARS in France,
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Physical interventions to interrupt or reduce the spread of respiratory viruses
Jefferson, T., Del Mar, C. B., Dooley, L., Ferroni, E., Al-Ansary, L. A., Bawazeer, G. A., van Driel, M. L., Nair, N. S., Jones, M. A., Thorning, S., et al. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006207.pub4 · Cited by 805
Virtual screening and repurposing of FDA approved drugs against COVID-19 main protease
Kandeel, M., & Al-Nazawi, M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117627 · Cited by 412
Physical interventions to interrupt or reduce the spread of respiratory viruses
Jefferson, T., Del Mar, C. B., Dooley, L., Ferroni, E., Al-Ansary, L. A., Bawazeer, G. A., van Driel, M. L., Jones, M. A., Thorning, S., Beller, E. M., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006207.pub5 · Cited by 318
Physical interventions to interrupt or reduce the spread of respiratory viruses
Jefferson, T., Dooley, L., Ferroni, E., Al-Ansary, L. A., van Driel, M. L., Bawazeer, G. A., Jones, M. A., Hoffmann, T. C., Clark, J., Beller, E. M., et al. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006207.pub6 · Cited by 291
Public health interventions and SARS spread, 2003
Bell, D. M., & World Health Organization Working Group on Prevention of International and Community Transmission of SARS (2004) · Emerging Infectious Diseases · doi:10.3201/eid1011.040729 · Cited by 272
Metadata
- Authors
- Desenclos, J.-C., van der Werf, S., Bonmarin, I., Levy-Bruhl, D., Yazdanpanah, Y., Hoen, B., Emmanuelli, J., Lesens, O., Dupon, M., Natali, F., Michelet, C., Reynes, J., Guery, B., Larsen, C., Semaille, C., Mouton, Y., Christmann, D., André, M., Escriou, N., Burguière, A., Manuguerra, J.-C., Coignard, B., Lepoutre, A., Meffre, C., Bitar, D., Decludt, B., Capek, I., Antona, D., Che, D., Herida, M., Infuso, A., Saura, C., Brücker, G., Hubert, B., LeGoff, D., & Scheidegger, S.
- Venue
- Emerging Infectious Diseases
- Published
- 2004-02
- Volume
- 10
- Issue
- 2
- Pages
- 195-200
- ISSN
- 1080-6040 (ISSN-L)
- 1080-6059
- OpenAlex
- W2050386855
- Cited by
- 53
- References
- 0
- FWCI
- 3.39
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Introduction of SARS in France, March–April, 2003. https://app.cochat.ai/papers/10.3201/eid1002.030351
- The paper
- Desenclos, J.-C., van der Werf, S., Bonmarin, I., Levy-Bruhl, D., Yazdanpanah, Y., Hoen, B., Emmanuelli, J., Lesens, O., Dupon, M., Natali, F., Michelet, C., Reynes, J., Guery, B., Larsen, C., Semaille, C., Mouton, Y., Christmann, D., André, M., Escriou, N., . . . Scheidegger, S. (2004). Introduction of SARS in France, March–April, 2003. Emerging Infectious Diseases. https://doi.org/10.3201/eid1002.030351
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.